[Changes in epidemiology of opportunistic infections due to Candida].
Odds
F C
FC
Departamento de Bacteriología y Micología, Janssen Research Foundation, Bélgica.
D017088:AIDS-Related Opportunistic Infections / Q000453:epidemiology; D000935:Antifungal Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D001769:Blood / Q000382:microbiology; D016026:Bone Marrow Transplantation; D002175:Candida / Q000187:drug effects / Q000302:isolation & purification; D002176:Candida albicans / Q000187:drug effects / Q000302:isolation & purification; D002177:Candidiasis / Q000453:epidemiology* / Q000382:microbiology / Q000517:prevention & control; D004352:Drug Resistance, Microbial; D015725:Fluconazole / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D015994:Incidence; D009503:Neutropenia / Q000150:complications; D009894:Opportunistic Infections / Q000453:epidemiology* / Q000382:microbiology / Q000517:prevention & control
D000935:Antifungal Agents; D015725:Fluconazole